Login to Your Account



Other News To Note


Monday, October 15, 2012
• Endocyte Inc., of West Lafayette, Ind., said data published in the Archives of Pathology & Laboratory Medicine showed that 72 percent of adenocarcinomas and 51 percent of squamous cell carcinomas of the lung were positive for the folate receptor.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription